Literature DB >> 24319170

Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.

Lawrence D Kaplan1.   

Abstract

Human herpesvirus 8 (HHV8) is a gamma herpesvirus associated with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma, lymphoproliferative diseases that are most commonly observed in immunocompromised individuals. The viral genome expresses genes responsible for inhibition of apoptosis, cell cycle entry, and angiogenesis. Viral homologs of human regulatory genes are expressed, providing stimuli for angiogenesis, B-cell proliferation, and immune evasion. Variations in expression of these factors give rise to the 3 known HHV8-associated malignancies. Identification of these pathogenetic mechanisms has led to exploration of targeted treatment approaches for all 3 of these disorders with success in Kaposi sarcoma and multicentric Castleman disease; primary effusion lymphoma remains a clinical challenge.

Entities:  

Mesh:

Year:  2013        PMID: 24319170     DOI: 10.1182/asheducation-2013.1.103

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  30 in total

1.  Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.

Authors:  J Chapman; A J Gentles; V Sujoy; F Vega; C I Dumur; T L Blevins; L Bernal-Mizrachi; M Mosunjac; A Pimentel; D Zhu; I S Lossos
Journal:  Leukemia       Date:  2015-04-24       Impact factor: 11.528

2.  Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Jason M Schifano; Kathleen Corcoran; Hemant Kelkar; Dirk P Dittmer
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.

Authors:  Bella Mehta; Shanthini Kasturi; Julie Teruya-Feldstein; Steven Horwitz; Anne R Bass; Doruk Erkan
Journal:  HSS J       Date:  2018-03-26

4.  BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells.

Authors:  Olesea Cojohari; Christine M Burrer; Megan A Peppenelli; Fardokht A Abulwerdi; Zaneta Nikolovska-Coleska; Gary C Chan
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 5.  Chemokines encoded by herpesviruses.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Leukoc Biol       Date:  2017-08-28       Impact factor: 4.962

Review 6.  The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.

Authors:  Faryal Mehwish Awan; Burton B Yang; Anam Naz; Aneeqa Hanif; Aqsa Ikram; Ayesha Obaid; Arif Malik; Hussnain Ahmed Janjua; Amjad Ali; Sumaira Sharif
Journal:  RNA Biol       Date:  2020-07-13       Impact factor: 4.652

7.  Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Christine M Burrer; Glenna W Foight; Amy E Keating; Gary C Chan
Journal:  Virus Res       Date:  2015-10-09       Impact factor: 3.303

8.  Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway.

Authors:  G Liu; F-X Yu; Y C Kim; Z Meng; J Naipauer; D J Looney; X Liu; J S Gutkind; E A Mesri; K-L Guan
Journal:  Oncogene       Date:  2014-09-08       Impact factor: 9.867

9.  Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy.

Authors:  Yi Liu; Gang Chen; Xiaoming Qiu; Song Xu; Yi Wu; Renwang Liu; Qinghua Zhou; Jun Chen
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

10.  Kaposi's Sarcoma-Associated Herpesvirus Fine-Tunes the Temporal Expression of Late Genes by Manipulating a Host RNA Quality Control Pathway.

Authors:  Julio C Ruiz; Anne M Devlin; Jiwoong Kim; Nicholas K Conrad
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.